|Bid||176.70 x 1000|
|Ask||176.61 x 1200|
|Day's range||174.07 - 177.15|
|52-week range||155.72 - 186.69|
|Beta (5Y monthly)||0.72|
|PE ratio (TTM)||26.45|
|Earnings date||18 Apr 2022 - 22 Apr 2022|
|Forward dividend & yield||4.52 (2.56%)|
|Ex-dividend date||23 May 2022|
|1y target est||191.42|
The Health Care Select Sector SPDR ETF and Johnson and Johnson have been highlighted in this Investment Ideas article.
This sector outperformance may be a sign the market is nearing a point of selling exhaustion.
Shares of Johnson & Johnson (NYSE: JNJ) climbed higher this morning and are trading up 2.2% as of 11 a.m. ET. The healthcare giant received a thumbs-up from an analyst, who sees roughly 14% upside in Johnson & Johnson stock from yesterday's close. Analyst David Risinger from healthcare-focused investment bank SVB Leerink gave Johnson & Johnson stock an outperform rating with a price target of $200 per share, according to TheFly.com.